The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive...
Keep Reading →
June 18 - Hedge Funds, News - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Keep Reading →
December 7 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
July 8 - Hedge Funds, News - Comments
COPENHAGEN (Reuters) - Hedge fund Marshall Wace is betting on Danske Bank (DANSKE.CO) shares falling after taking a short position in the Danish lender of 0.5% of issued shares...
Keep Reading →
January 3 - Hedge Funds, Insider Trading - Comments
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Keep Reading →
December 12 - Hedge Funds, News - Comments
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Keep Reading →
November 6 - Hedge Funds, News - Comments
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong.
Keep Reading →
June 20 - Hedge Funds, News - Comments
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter.
Keep Reading →
May 9 - Hedge Funds, News - Comments
(Bloomberg) -- It has been yet another year to forget in the world of hedge funds.
Keep Reading →
December 27 - Hedge Funds, Insider Trading - Comments
Hedge fund titan David Tepper said Thursday the Federal Reserve is sending the market a message, and it’s not a good one.
Keep Reading →
December 20 - Hedge Funds, Insider Trading - Comments
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed...
Keep Reading →
December 14 - Hedge Funds, News - Comments
(Reuters) - Activist investor John Paulson’s hedge fund on Thursday said it would urge Detour Gold Corp (DGC.TO) to call a special shareholder meeting to replace a majority ...
Keep Reading →
July 19 - Hedge Funds, Insider Trading - Comments
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...
Keep Reading →
February 28 - Hedge Funds - Comments
(Reuters) - Och-Ziff Capital Management on Tuesday named Robert Shafir as its new chief executive officer, succeeding Dan Och after a battle over who will run the hedge fund firm...
Keep Reading →
January 30 - Hedge Funds, Insider Trading - Comments
Elliott Management Corp., the hedge fund founded by billionaire Paul Singer, has built a stake in Sky Plc as shareholders prepare to vote on 21st Century Fox Inc.’s 11.7-billion...
Keep Reading →
January 29 - Hedge Funds, Insider Trading - Comments
Shares of Nike (NYSE:NKE) rose over 3% Friday morning following an upgrade by Wedbush to Outperform (from Neutral) with a new price target of $74.00 (from $57.00).
Keep Reading →
January 19 - Market Movers, News - Comments
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d...
Keep Reading →
September 11 - Hedge Funds - Comments
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...
Keep Reading →
August 8 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
July 10 - Hedge Funds - Comments
“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.
Keep Reading →
April 3 - Commodities, Gold, Market Movers, News, Tech - Comments
In order to ensure an extension of Ampyra’s protection to 2026, Acorda Therapeutics Inc (NASDAQ:ACOR) must fight off competition from competitors such as Roxane, Teva Pharmaceutical...
Keep Reading →
February 16 - News, Stock Analysis - Comments
Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE:LLY) severe competition...
Keep Reading →
January 24 - News, Stock Analysis - Comments
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Keep Reading →
November 28 - Hedge Funds, News - Comments
To find a winner in the biotech space this week, all you’d need to do is throw a dart at a basket of micro-caps.
Keep Reading →
November 22 - Market Movers, News, Stock Analysis - Comments
The markets continue to trade down in anticipation of the upcoming OPEC meeting.
Keep Reading →
September 26 - Market Movers, News - Comments
Acorda Therapeutics Inc (NASDAQ:ACOR) is a $1.11 billion biotechnology company that develops and commercializes novel therapies for neurological disorders.
Keep Reading →
August 31 - News, Stock Analysis - Comments
We just got a couple of updates in the Parkinson’s space, and both have the potential to serve up some volatility in the market capitalisations of the companies in question.
Keep Reading →
August 5 - News, Stock Analysis - Comments
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Keep Reading →
November 30 - Hedge Funds, News - Comments
While many hedge funds are still preparing their third quarter filings with the SEC, providing the main ingredients for our delectable small-cap investment strategy, some managers...
Keep Reading →
November 2 - Commodities, Hedge Funds, News - Comments
Those who seek to profit from shorting strategies should keep a close eye on Kyle Bass’ war against the pharmaceutical industry.
Keep Reading →
September 17 - Hedge Funds, Macroeconomic Predictions, News - Comments
The shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are trading 13.16% higher today after the dismissal of a patent challenge against the company.
Keep Reading →
August 25 - Hedge Funds, Market Movers, News - Comments
Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment vehicles of a forgotten age.
Keep Reading →
September 17 - News - Comments
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age.
Keep Reading →
September 11 - News - Comments
If you were to ask many of your fellow readers, hedge funds are seen as overrated, old investment vehicles of a period lost to current times.
Keep Reading →
August 30 - News - Comments
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Keep Reading →
August 22 - News - Comments
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Keep Reading →
August 6 - News - Comments
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds' portfolio at the end of March.
Keep Reading →
June 12 - News - Comments
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of March. ACOR has experienced a decrease in hedge fund sentiment lately.
Keep Reading →
June 8 - News - Comments
Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds' portfolio at the end of March.
Keep Reading →
June 3 - News - Comments
Small biotech companies have great investment potential if you can identify them properly.
Keep Reading →
April 24 - News - Comments
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Keep Reading →
April 20 - News - Comments
Biogen Idec Inc.
Keep Reading →
April 17 - News - Comments
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.
Keep Reading →
April 15 - News - Comments
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of the fourth quarter of 2012.
Keep Reading →
April 12 - News - Comments